Info

Mastering Money

Mastering Money is hosted by Certified Income Specialist™ Steve Jurich. Steve's comments have been seen on MarketWatch, CNBC.com, Bloomberg, and TheStreet.com. Steve is joined on most days by Money Radio favorite Sinclair Noe as well as experts and authors from the world of Wall Street and real estate. New episodes published every weekday at 9am PST. Listen every weekday to get a handle on emerging market trends, asset allocation strategies, social security, medicare, RMD planning, tax strategies, estate planning, annuities, life insurance and more!
RSS Feed Subscribe in Apple Podcasts Android App iOS App
2018
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May
April
March
February
January


2015
December
November
October
September
August
July
June
May
April
March
February


Categories

All Episodes
Archives
Categories
Now displaying: 2017

Jan 6, 2017

Until now, the science of futurism has been practiced mostly by large organizations making decisions that might not become policy or products for many years to come. Big companies like Ford and IBM as well as government agencies and especially the Department of Defense--all employ futurists. What do futurists do? According to Christopher Mims of the Wall Street Journal, they do everything BUT make predictions. They make calculations. Steve and Sinclair have the intriguing Wall Street Journal story you don't want to miss.

Jan 5, 2017

Investment researchers in retail stocks used to count cars in parking lots with aerial photos, track foot traffic in malls and look for discounts on the racks. Today, they skip all that and buy data on credit- and debit-card transactions to gain an edge ahead of earnings news. Find out the remarkable effect it's having on retail stocks right now. Steve and Sinclair have the Wall Street Journal report. Then estate planning attorney and MBA Richard Dwornik is in the house for the Q & A.

Jan 4, 2017

Biotech stocks can be huge winners but have taken a beating for quite some time. Is that about to change in 2017 with reduced regulations coming in health care?  Learn what a prominent Certified Financial Analyst has to say, and learn about the difference between biotech investing and pharmaceutical investing!

Jan 3, 2017

Happy New Year!  ...Now let's go to work and take a close look at stocks that may perform well under a Trump presidency. Steve and Sinclair will review 9 stocks being touted by analysts at Fortune.com and The Street.com.  Then Steve and Sinclair review the IQ Wealth Blue Diamond Tax Deferred selection of funds, including entries from Black Rock, Fidelity, ClearBridge, Ivy, and Oppenheimer.

1 « Previous 20 21 22 23 24 25 26